A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients

Erica E.M. Moodie, David A. Stephens, Shomoita Alam, Mei Jie Zhang, Brent Logan, Mukta Arora, Stephen Spellman, Elizabeth F. Krakow

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Cancers treated by transplantation are often curative, but immunosuppressive drugs are required to prevent and (if needed) to treat graft-versus-host disease. Estimation of an optimal adaptive treatment strategy when treatment at either one of two stages of treatment may lead to a cure has not yet been considered. Using a sample of 9563 patients treated for blood and bone cancers by allogeneic hematopoietic cell transplantation drawn from the Center for Blood and Marrow Transplant Research database, we provide a case study of a novel approach to Q-learning for survival data in the presence of a potentially curative treatment, and demonstrate the results differ substantially from an implementation of Q-learning that fails to account for the cure-rate.

Original languageEnglish (US)
Pages (from-to)442-453
Number of pages12
JournalBiometrical Journal
Volume61
Issue number2
DOIs
StatePublished - Mar 1 2019
Externally publishedYes

Fingerprint

Cure Rate Model
Q-learning
Transplantation
Cell
Blood
Cancer
Survival Data
Bone
Drugs
Strategy
Demonstrate

Keywords

  • Q-learning
  • adaptive treatment strategy
  • cure-rate
  • dynamic treatment regime
  • survival data

PubMed: MeSH publication types

  • Journal Article
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

Cite this

A cure-rate model for Q-learning : Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. / Moodie, Erica E.M.; Stephens, David A.; Alam, Shomoita; Zhang, Mei Jie; Logan, Brent; Arora, Mukta; Spellman, Stephen; Krakow, Elizabeth F.

In: Biometrical Journal, Vol. 61, No. 2, 01.03.2019, p. 442-453.

Research output: Contribution to journalArticle

Moodie, Erica E.M. ; Stephens, David A. ; Alam, Shomoita ; Zhang, Mei Jie ; Logan, Brent ; Arora, Mukta ; Spellman, Stephen ; Krakow, Elizabeth F. / A cure-rate model for Q-learning : Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients. In: Biometrical Journal. 2019 ; Vol. 61, No. 2. pp. 442-453.
@article{cd20f53bf97946269ab4dc18bf31683d,
title = "A cure-rate model for Q-learning: Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients",
abstract = "Cancers treated by transplantation are often curative, but immunosuppressive drugs are required to prevent and (if needed) to treat graft-versus-host disease. Estimation of an optimal adaptive treatment strategy when treatment at either one of two stages of treatment may lead to a cure has not yet been considered. Using a sample of 9563 patients treated for blood and bone cancers by allogeneic hematopoietic cell transplantation drawn from the Center for Blood and Marrow Transplant Research database, we provide a case study of a novel approach to Q-learning for survival data in the presence of a potentially curative treatment, and demonstrate the results differ substantially from an implementation of Q-learning that fails to account for the cure-rate.",
keywords = "Q-learning, adaptive treatment strategy, cure-rate, dynamic treatment regime, survival data",
author = "Moodie, {Erica E.M.} and Stephens, {David A.} and Shomoita Alam and Zhang, {Mei Jie} and Brent Logan and Mukta Arora and Stephen Spellman and Krakow, {Elizabeth F.}",
year = "2019",
month = "3",
day = "1",
doi = "10.1002/bimj.201700181",
language = "English (US)",
volume = "61",
pages = "442--453",
journal = "Biometrical Journal",
issn = "0323-3847",
publisher = "Wiley-VCH Verlag",
number = "2",

}

TY - JOUR

T1 - A cure-rate model for Q-learning

T2 - Estimating an adaptive immunosuppressant treatment strategy for allogeneic hematopoietic cell transplant patients

AU - Moodie, Erica E.M.

AU - Stephens, David A.

AU - Alam, Shomoita

AU - Zhang, Mei Jie

AU - Logan, Brent

AU - Arora, Mukta

AU - Spellman, Stephen

AU - Krakow, Elizabeth F.

PY - 2019/3/1

Y1 - 2019/3/1

N2 - Cancers treated by transplantation are often curative, but immunosuppressive drugs are required to prevent and (if needed) to treat graft-versus-host disease. Estimation of an optimal adaptive treatment strategy when treatment at either one of two stages of treatment may lead to a cure has not yet been considered. Using a sample of 9563 patients treated for blood and bone cancers by allogeneic hematopoietic cell transplantation drawn from the Center for Blood and Marrow Transplant Research database, we provide a case study of a novel approach to Q-learning for survival data in the presence of a potentially curative treatment, and demonstrate the results differ substantially from an implementation of Q-learning that fails to account for the cure-rate.

AB - Cancers treated by transplantation are often curative, but immunosuppressive drugs are required to prevent and (if needed) to treat graft-versus-host disease. Estimation of an optimal adaptive treatment strategy when treatment at either one of two stages of treatment may lead to a cure has not yet been considered. Using a sample of 9563 patients treated for blood and bone cancers by allogeneic hematopoietic cell transplantation drawn from the Center for Blood and Marrow Transplant Research database, we provide a case study of a novel approach to Q-learning for survival data in the presence of a potentially curative treatment, and demonstrate the results differ substantially from an implementation of Q-learning that fails to account for the cure-rate.

KW - Q-learning

KW - adaptive treatment strategy

KW - cure-rate

KW - dynamic treatment regime

KW - survival data

UR - http://www.scopus.com/inward/record.url?scp=85047468536&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047468536&partnerID=8YFLogxK

U2 - 10.1002/bimj.201700181

DO - 10.1002/bimj.201700181

M3 - Article

C2 - 29766558

AN - SCOPUS:85047468536

VL - 61

SP - 442

EP - 453

JO - Biometrical Journal

JF - Biometrical Journal

SN - 0323-3847

IS - 2

ER -